A Yale project involving the independent review of a bone growth product's safety has yielded results, which are published in the June 18 issue of Annals of Internal Medicine. The findings are part of the Yale University ...
Jun 17, 2013
0
0
(HealthDay)—For patients hospitalized for lumbar spinal stenosis (LSS), the rate of fusions significantly increased and the rate of decompressions significantly decreased from 2004 to 2009 in the United States, according ...
Jun 13, 2013
0
0
(HealthDay)—For patients with lumbar spondylosis or spondylolisthesis of the lowest lumbar levels who undergo open anterior lumbar interbody fusion (ALIF), use of recombinant human bone morphogenetic protein-2 (rhBMP-2) ...
Dec 29, 2012
0
0
A new study has shown that heparan sulfate, a desirable natural material for use in bioengineered tissues and orthotic implants, can withstand the stress of gamma irradiation for sterilization and retain its structure, binding ...
Jan 25, 2018
0
2
Researchers have designed a 3D-printed porous scaffold for use in reconstructing ruptured anterior cruciate ligaments (ACL) in the knee and engineered it to deliver a human bone-promoting protein over an extended period of ...
Feb 27, 2017
0
0
A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, has created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation. The combination ...
Dec 5, 2016
0
2
Patients undergoing spinal fusion surgery with bone morphogenetic protein (BMP) appear to be at increased risk of benign tumors—but not cancers, reports a study in the September issue of Neurosurgery, official journal of ...
Sep 6, 2013
0
0
Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years after being implanted with the product, according to a new ...
Nov 4, 2011
0
1
